Skip to content
Search

Latest Stories

NPA will become more “militant” as wait for pharmacy contract goes on

NPA members are expected reduce opening hours and services from next week

NPA members are expected reduce opening hours and services from next week

Pic credit: iStock

The government has been warned by the National Pharmacy Association (NPA) that community pharmacy will not back down from collective action and reducing opening hours from April 1st.

NPA board member, Ashley Cohen, told LBC today that the sector was in a "desperate situation" and that the representative body will do “whatever we can to protect our sector”.


“We're becoming more angry, more frustrated and more militant as the weeks and the months go by and getting to a point to almost say that ‘enough is enough’,” said Cohen.

Pharmacy minister Stephen Kinnock previously told Pharmacy Business that he was “disappointed” by the NPA’s decision to push for collective action and that the government was “working at pace and have rolled up our sleeves to resolve the issues”.

However, pharmacies have seen around a 40 per cent cut to this funding in real terms since 2017, forcing record numbers to close. Around 1,300 pharmacies have shut down since 2017 including 29 since January.

Additional unfunded costs due to hit pharmacies on April 1st include National Insurance, National Living Wage and Business rates, on top of a decade of real terms cuts which may jeopardise patient safety if a resolution is not found.

The NPA announced last week that will advise its 6000 member pharmacies in England to take the unprecedented step in the face of what it has described as an April cliff-edge that will see a range of financial burdens placed on the sector.

“Is it best for us to reduce our opening hours rather than to close permanently? I would have thought that the latter would be the case,” said Cohen, who is also chair of Community Pharmacy West Yorkshire.

“However inconvenienced it might be, we need to do something and be in control of our decisions. So maybe reducing our hours, reducing some services to protect the sector in the long term is what's needed at the moment. But as soon as we do get a settlement, we can very quickly stop this collective action.

“It's taken many years and many unanswered questions in terms of the government, to get to this state.”

Cohen revealed that in the last 12 months, he has had to put in £125,000 of his own money just to keep his business going.

He explained how the rise in NI contributions will have a massive impact on community pharmacies.

“We are a profession and what's really vitally important is that we have a contract with the government, which represents up to 90 per cent of our funding. So unlike other businesses that may be able to increase their prices or make some changes, we can't do that, we're held to a government contract, a contract that has been static for nearly a decade now,” he said.

“In some respects, I feel that we are treated a little bit like second class citizens in healthcare, where family doctors, our GP colleagues, are basically felt as part of the NHS family - but we're referred to as businesses even though our contract is very similar, almost identical to GP contracts and that's frustrating.”

More For You

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less